Under which act was a regulatory pathway for biosimilars or follow-on biologicals established?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $24.99Unlock all

Study for the BCPS Regulatory Test. Prepare with flashcards and multiple choice questions, each question includes hints and explanations to get you ready for the exam!

Multiple Choice

Under which act was a regulatory pathway for biosimilars or follow-on biologicals established?

Explanation:
The regulatory pathway for biosimilars was established by the Patient Protection and Affordable Care Act, which incorporated the Biologics Price Competition and Innovation Act to create an abbreviated licensure pathway for biosimilars under FDA oversight. This framework allows follow-on biologics to be approved based on similarity to a reference biologic, promoting competition and potential cost savings. The other acts address different areas (tobacco control, general FDA modernization, or broad health care reform) and do not establish the biosimilar pathway.

The regulatory pathway for biosimilars was established by the Patient Protection and Affordable Care Act, which incorporated the Biologics Price Competition and Innovation Act to create an abbreviated licensure pathway for biosimilars under FDA oversight. This framework allows follow-on biologics to be approved based on similarity to a reference biologic, promoting competition and potential cost savings. The other acts address different areas (tobacco control, general FDA modernization, or broad health care reform) and do not establish the biosimilar pathway.

More Multiple Choice Questions
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy